Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon

Gut

Volumn 47, Issue 3, 2000, Pages 370-376

  Jeppesen, P B ^a   Hartmann, B ^b   Thulesen, J ^b   Hansen, B S ^a   Holst, J J ^b   Poulsen, S S ^b   Mortensen, P B ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Colon; Glucagon like peptides; Intestinal adaptation; Intestinal transit; Short bowel syndrome

Indexed keywords

GLUCAGON LIKE PEPTIDE; GLUCAGON LIKE PEPTIDE 1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; ILEUM RESECTION; INTESTINE ADAPTATION; INTESTINE MOTILITY; INTESTINE TRANSIT TIME; MALE; PRIORITY JOURNAL; SHORT BOWEL SYNDROME;

ADAPTATION, PHYSIOLOGICAL; ADULT; AGED; AREA UNDER CURVE; CASE-CONTROL STUDIES; FASTING; FEMALE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDE 2; HUMANS; ILEUM; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PEPTIDES; POSTPRANDIAL PERIOD; PROTEIN PRECURSORS; RADIOIMMUNOASSAY; SHORT BOWEL SYNDROME;

EID: 0033857217     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.47.3.370     Document Type: Article

References (67)

1. 1 Unger RH, Eisentraut AM, Sims K, et al. Site of origin of glucagon in dogs and humans. South Soc Clin Res 1961;9:53.
2. 2 Gleeson MH, Bloom SR, Polak JM, et al. Endocrine tumour in kidney affecting small bowel structure, motility, and function. Gut 1971;12:773-82.
3. 3 Stevens FM, Flanagan RW, O'Gorman D, et al. Glucagonoma syndrome demonstrating giant duodenal villi. Gut 1984;25:784-91.
4. 4 Drucker DJ, Erlich P, Asa SL, et al. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA 1996;93:7911-16.
5. 5 Tsai CH, Hill M, Drucker DJ. Biological determinants of intestinotrophic properties of GLP-2 in vivo. Am J Physiol 1997;272:G662-8.
6. 6 Tsai CH, Hill M, Asa SL, et al. Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. Am J Physiol 1997;273:E77-84.
7. 7 Holst JJ. Evidence that glicentin contains the entire sequence of glucagon. Biochem J 1980;187:337-43.
8. 8 Thim L, Moody AJ. The primary structure of porcine glicentin (proglucagon). Regul Pept 1981;2:139-50.
9. 9 Orskov C, Hoist JJ, Knuhtsen S, et al. Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas. Endocrinology 1986;119:1467-75.
10. 10 Varndell IM, Bishop AE, Sikri KL, et al. Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry. J Histochem Cytochem 1985;33: 1080-6.
11. 11 Larsson LI, Hoist J, Hakanson R, et al. Distribution and properties of glucagon immunoreactivity in the digestive tract of various mammals: an immunohistochemical and immunochemical study. Histochemistry 1975;44:281-90.
12. 12 Hoist JJ. Enteroglucagon. Annu Rev Physiol 1997;59:257-71.
13. 13 Holst JJ, Orskov C, Nielsen OV, et al. Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut. FEBS Lett 1987;211:169-74.
14. 14 Mojsov S, Weir GC, Habener JF. Insulinotropin:glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 1987;79:616-19.
15. 15 Holst JJ. Glucagonlike peptide 1 : a newly discovered gastrointestinal hormone. Gastroenterology 1994;107:1848-55.
16. 16 Wojdemann M, Wettergren A, Hartmann B, et al. Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs. Scand J Gastroenterol 1998;33:828-32.
17. 17 Wojdemann M, Wettergren A, Hartmann B, et al. Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2. J Clin Endocrinol Metab 1999;84: 2513-17.
18. 18 Scott RB, Kirk D, MacNaughton WK, et al. GLP-2 augments the adaptive response to massive intestinal resection in rat. Am J Physiol 1998;275:G911-21.
19. 19 Thulesen J, Hartmann B, Kissow H, et al. Intestinal growth adaptation and circulating levels of glucagon-like peptide 2 (GLP-2) following small bowel resection or ileal-jejunal transposition in rats. Dig Dis Sci 2000 (submitted).
20. 20 Jeppesen PB, Hartmann B, Hansen BS, et al. Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure. Gut 1999;45:559-63.
21. 21 Dowling RH. Small bowel adaptation and its regulation. Scand J Gastroenterol Suppl 1982;74:53-74.
22. 22 Carbonnel F, Cosnes J, Chevret S, et al. The role of anatomic factors in nutritional autonomy after extensive small bowel resection. JPEN J Parenter Enteral Nutr 1996; 20:275-80.
23. 23 Nightingale JM, Lennard Jones JE, Walker ER, et al. Jejunal efflux in short bowel syndrome (see comments). Lancet 1990;336:765-8.
24. 24 Nightingale JM, Lennard Jones JE, Gertner DJ, et al. Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel. Gut 1992;33:1493-7.
25. 25 Cosnes J, Carbonnel F, Beaugerie L, et al. Functional adaptation after extensive small bowel resection in humans. Eur J Gastroenterol Hepatol 1994;6:197-202.
26. 26 Nordgaard I, Hansen BS, Mortensen PB. Importance of colonic support for energy absorption as small-bowel failure proceeds. Am J Clin Nutr 1996;64:222-31.
27. 27 Cummings JH, James WP, Wiggins HS. Role of the colon in ileal-resection diarrhoea. Lancet 1973;1:344-7.
28. 28 Schofield WN. Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr 1985;39(suppl 1):5-41.
29. 29 Jeppesen PB, Staun M, Mortensen PB. Adult patients receiving home parenteral nutrition in Denmark from 1991 to 1996: who will benefit from intestinal transplantation? Scand J Gastroenterol 1998;33:839-46.
30. 30 Jeppesen PB, Mortensen PB. Intestinal failure denned by measurements of intestinal energy and wet weight absorption. Gut 2000;46:701-6.
31. 31 Jeppesen PB, Staun M, Tjellesen L, et al. Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection. Gut 1998;43:763-9.
32. 32 Jeppesen PB, Mortensen PB. The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection. Gut 1998;43:478-83.
33. 33 Levnedsmiddelstyrelsen (National Food Agency of Denmark), Dankost version 1.3a. Stork¢kken centret (The Stork¢kken Center), Herlev, Denmark: Levdedsmiddelstyrelsen, 1989.
34. 34 Hartmann B, Johnsen AH, Ørskov C, Adelhorst K, Thim L, Holst JJ. Structure, measurement and secretion of human glucagon-like peptide-2. Peptides 2000;21:73-80.
35. 35 Hvidberg A, Nielsen MT, Hilsted J, et al. Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man. Metabolism 1994;43:104-8.
36. 36 Holst JJ, Bersani M, Johnsen AH, Kofod H, Hartmann B, Orskov C. Proglucagon processing in porcine and human pancreas. J Biol Chem 1994;269:18827-33.
37. 37 Holst JJ. Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin. Biochem J 1982;207:381-8.
38. 38 Xiao Q, Boushey RP, Drucker DJ, et al Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans (see comments). Gastroenterology 1999;117:99-105.
39. 39 Roberge JN, Brubaker PL. Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop. Endocrinology 1993;133:233-40.
40. 40 Rocca AS, Brubaker PL. Stereospecific effects of fatty acids on proglucagon-derived peptide secretion in fetal rat intestinal cultures. Endocrinology 1995;136:5593-9.
41. 41 Rocca AS, Brubaker PL. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology 1999;140:1687-94.
42. 42 Nordgaard I, Mortensen PB, Langkilde AM. Small intestinal malabsorption and colonic fermentation of resistant starch and resistant peptides to short-chain fatty acids (see comments). Nutrition 1995;11:129-37.
43. 43 Nordgaard I, Hansen BS, Mortensen PB. Colon as a digestive organ in patients with short bowel (see comments). Lancet 1994;343:373-6.
44. 44 Kripke SA, De Paula JA, Bcrman JM, et al. Experimental short-bowel syndrome: effect of an elemental diet supplemented with short-chain triglycerides. Am J Clin Nutr 1991;53:954-62.
45. 45 Kripke SA, Fox AD, Berman JM, et al. Stimulation of intestinal mucosal growth with intracolonic infusion of short-chain fatty acids. JPEN J Parenter Enteral Nutr 1989;13: 109-16.
46. 46 Frankel WL, Zhang W, Singh A, et al. Mediation of the trophic effects of short-chain fatty acids on the rat jejunum and colon. Gastroenterology 1994;2:375-80.
47. 47 Koruda MJ, Rolandelli RH, Bliss DZ, et al. Parenteral nutrition supplemented with short-chain fatty acids: effect on the small-bowel mucosa in normal rats. Am J Clin Nutr 1990;51:685-9.
48. 48 Windmueller HG, Spaeth AE. Identification of ketone bodies and glutamine as the major respiratory fuels in vivo for postabsorptive rat small intestine. J Biol Chem 1978;253: 69-76.
49. 49 Sakata T. Stimulatory effect of short-chain fatty acids on epithelial cell proliferation of isolated and denervated jejunal segment of the rat. Scand J Gastroenterol 1989;24:886-90.
50. 50 Tappenden KA, Drozdowski LA, Thomson AB, et al. Short-chain fatty acid-supplemented total parenteral nutrition alters intestinal structure, glucose transporter 2 (GLUT2) mRNA and protein, and proglucagon mRNA abundance in normal rats. Am J Clin Nutr 1998;68:118-25.
51. 51 Bloom SR, Polak JM. The hormonal pattern of intestinal adaptation. A major role for enteroglucagon. Scand J Gastroenterol Suppl 1982;14:93-103.
52. 52 Sagor GR, Ghatei MA, Al Mukhtar MY, et al. Evidence for a humoral mechanism after small intestinal resection. Exclusion of gastrin but not enteroglucagon. Gastroenterology 1983;84:902-6.
53. 53 Rountree DB, Ulshen MH, Selub S, et al. Nutrient-independent increases in proglucagon and ornithine decarboxylase messenger RNAs after jejunoileal resection. Gastroenterology 1992;103:462-8.
54. 54 Taylor RG, Verity K, Fuller PJ. Ileal glucagon gene expression: ontogeny and response to massive small bowel resection. Gastroenterology 1990;99:724-9.
55. 55 Morin CL, Ling V, Bourassa D. Small intestinal and colonic changes induced by a chemically defined diet. Dig Dis Sci 1980;25:123-8.
56. 56 Cassidy MM, Lightfoot FG, Grau LE, et al. Effect of chronic intake of dietary fibers on the ultrastructural topography of rat jejunum and colon: a scanning electron microscopy study. Am J Clin Nutr 1981;34:218-28.
57. 57 Sagor GR, Al Mukhtar MY, Ghatei MA, et al. The effect of altered luminal nutrition on cellular proliferation and plasma concentrations of enteroglucagon and gastrin after small bowel resection in the rat. Br J Surg 1982;69:14-18.
58. 58 Goodlad RA, Lenton W, Ghatei MA, et al. Effects of an elemental diet, inert bulk and different types of dietary fibre on the response of the intestinal epithelium to refeeding in the rat and relationship to plasma gastrin, enteroglucagon, and PYY concentrations. Gut 1987;28:171-80.
59. 59 Jenkins AP, Thompson RP. Enteral nutrition and the small intestine (see comments). Gut 1994;35:1765-9.
60. 60 Izukura M, Evers BM, Parekh D, et al. Neurotensin augments intestinal regeneration after small bowel resection in rats. Ann Surg 1992;215:520-6.
61. 61 Evers BM, Izukura M, Townsend CM, et al. Neurotensin prevents intestinal mucosal hypoplasia in rats fed an elemental diet. Dig Dis Sci 1992;37:426-31.
62. 62 Nightingale JM, Kamm MA, van der Sijp JR, et al. Disturbed gastric emptying in the short bowel syndrome. Evidence for a 'colonic brake'. Gut 1993;34:1171-6.
63. 63 Adrian TE, Ferri GL, Bacarese Hamilton AJ, et al. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 1985;89:1070-7.
64. 64 Nightingale JM, Kamm MA, van der Sijp JR, et al. Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake' to gastric emptying. Gut 1996;39:267-72.
65. 65 Savage AP, Gornacz GE, Adrian TE, et al. Is raised plasma peptide YY after intestinal resection in the rat responsible for the trophic response? Gut 1985;26:1353-8.
66. 66 Messing B, Landais P, Goldfarb B, et al. Home parenteral nutrition in adults: a multicentre survey in Europe. Clin Nutr 1989;8:3-9.
67. 67 Van Gossum A, Bakker H, De Francesco A, et al. Home parenteral nutrition in adults: a multicentre survey in Europe in 1993. Clin Nutr 1996;15:53-9.